Indication
Acute Pyelonephritis
1 clinical trial
2 products
Clinical trial
A Multi-center, Randomized, Double-blind, Active Controlled, Parallel Groups, Phase II Study to Evaluate the Efficacy and Safety of Intravenous HRS-8427 in the Treatment of Adults With Complicate Urinary Tract Infection, Including Acute PyelonephritisStatus: Not yet recruiting, Estimated PCD: 2024-06-01
Product
Imipenem + CilastatinProduct
HRS-8427